Skip to main content
GutCited

Small Intestinal Bacterial Overgrowth (SIBO)

Prevalence: Estimated 6-15% in healthy population; up to 80% in IBS patients

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'condition\u003Dsibo'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Evidence-Ranked Ingredients

Ingredient Grade Studies Direction
Partially Hydrolyzed Guar Gum (PHGG) C 2 Positive View →
Berberine C 2 Positive View →

About

A condition characterized by excessive bacterial colonization of the small intestine, typically defined as >10^5 CFU/mL on jejunal aspirate or positive lactulose/glucose hydrogen breath test. Causes malabsorption due to bacterial consumption of nutrients and bile acid deconjugation.

Common Symptoms

Bloating Gas Abdominal pain Diarrhea Steatorrhea Vitamin B12 deficiency Iron deficiency Weight loss Brain fog

Risk Factors

  • IBS
  • Gastric acid suppression (PPIs)
  • Structural abnormalities
  • Diabetes
  • Hypothyroidism
  • Prior abdominal surgery
  • Chronic opioid use

Frequently Asked Questions

What supplements are studied for Small Intestinal Bacterial Overgrowth (SIBO)?
Research has examined 2 supplement ingredients for Small Intestinal Bacterial Overgrowth (SIBO), including Partially Hydrolyzed Guar Gum (PHGG). Evidence strength varies; review individual grades for details.
How is the evidence for Small Intestinal Bacterial Overgrowth (SIBO) supplements graded?
We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
How many studies on Small Intestinal Bacterial Overgrowth (SIBO) supplements have been reviewed?
Our evidence grades for Small Intestinal Bacterial Overgrowth (SIBO) are based on a total of 4 peer-reviewed studies across 2 ingredients. Studies are sourced from PubMed and include randomized controlled trials, meta-analyses, and other clinical research.
What are common symptoms of Small Intestinal Bacterial Overgrowth (SIBO)?
Common symptoms associated with Small Intestinal Bacterial Overgrowth (SIBO) include Bloating, Gas, Abdominal pain, Diarrhea, Steatorrhea. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.

Related Conditions

Conditions that share studied ingredients

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.